Mangayao, Mary Blance B.
HRN: 17-03-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
CEFUROXIME 500MG (TAB)
05/25/2023
06/01/2023
PO
500mg
BID X 7 Days
2nd Degree RMLE And Repair; Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes